共 50 条
Neoantigen Vaccines Pass the Immunogenicity Test
被引:35
|作者:
Linette, Gerald P.
[1
,2
]
Carreno, Beatriz M.
[2
,3
]
机构:
[1] Univ Penn, Perelman Sch Med, Parker Inst Canc Immunotherapy, Dept Hematol Oncol, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA
[3] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA
基金:
美国国家卫生研究院;
关键词:
D O I:
10.1016/j.molmed.2017.08.007
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
Neoantigens arising from tumor-specific genomic alterations constitute authentic non-self antigens and represent a new class of targets for cancer immunotherapy. Recent reports on various vaccine platforms targeting neoantigens suggest a basis for precision therapies customized to each patient's tumor mutational profile.
引用
收藏
页码:869 / 871
页数:3
相关论文